Masanori Kawakami - Concepedia

Author

Masanori Kawakami

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

M Kawakami, M. Kawakami, M., Kawakami, Masanori Kawakami

159

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Frederick National Laboratory for Cancer Research University of Tokyo Hospital Dartmouth College The University of Tokyo

About

Masanori Kawakami is an author at The University of Texas MD Anderson Cancer Center specializing in tumor biology, lung cancer, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	271
2	Engineering	2	2	25
3	Health Sciences	2	2	34
4	Biochemistry	2	2	67
5	Natural Sciences	1	1	21

Masanori Kawakami

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade Limo Chen, Lixia Diao, Yongbin Yang, Cancer Discovery	2018	457
A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components Monique B. Nilsson, Huiying Sun, Jacqulyne Robichaux, Science Translational Medicine	2020	171
Genome structure‐based screening identified epigenetically silenced microRNA associated with invasiveness in non‐small‐cell lung cancer Kousuke Watanabe, Noriko Emoto, Emi Hamano, International Journal of Cancer Epigenetic ChangeDna MethylationPathologyEpigeneticsTumor Biology	2011	97
Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers Masanori Kawakami, Lisa Maria Mustachio, Lin Zheng, Proceedings of the National Academy of Sciences	2018	86
The Ubiquitin-Specific Peptidase USP18 Promotes Lipolysis, Fatty Acid Oxidation, and Lung Cancer Growth Xi Liu, Yun Lu, Zibo Chen, Molecular Cancer Research Usp18 ExpressionProtein FunctionLipid SynthesisBiochemistryMedicine	2020	56
The ISG15-specific protease USP18 regulates stability of PTEN Lisa Maria Mustachio, Masanori Kawakami, Yun Lu, Oncotarget	2016	51
Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via Inhibition of Cyclin-Dependent Kinases 1 and 2 Alexey V. Danilov, Shanhu Hu, Bernardo Orr, Molecular Cancer Therapeutics ApoptosisCell DeathCell CycleCancer BiologyTumor Biology	2016	49
Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer Masanori Kawakami, Lisa Maria Mustachio, Jaime Rodriguez‐Canales, JNCI Journal of the National Cancer Institute	2016	47
Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer Lisa Maria Mustachio, Yun Lu, Laura J. Tafe, Molecular Cancer Research	2017	43
Tyrosine Threonine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and Polyploidy Lin Zheng, Zibo Chen, Masanori Kawakami, Molecular Cancer Therapeutics	2019	38

Page 1